Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections

Document Type

Letter to the Editor

Publication Date

9-1-2020

Publication Title

Drug Development Research

ISSN

0272-4391

Volume

81

Issue/No.

6

First Page

643

Last Page

646

ORCID ID

0000-0002-6434-2145

DOI

10.1002/ddr.21672

Peer Reviewed

Find in your library

Share

COinS